AF
LFCR icon

Allworth Financial’s Lifecore Biomedical LFCR Stock Holding History

Allworth Financial’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.08K Buy
586
+60
+11% +$302 ﹤0.01% 4340
2026
Q1 		$1.96K Buy
526
+26
+5% +$180 ﹤0.01% 4362
2025
Q4 		$4.09K Hold
500
– – ﹤0.01% 3829
2025
Q3 		$3.68K Hold
500
– – ﹤0.01% 3713
2025
Q2 		$4.06K Buy
+500
New +$3.37K ﹤0.01% 3376

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Allworth Financial's LFCR Position: Q2 2026 in Review

Allworth Financial increased its Lifecore Biomedical (LFCR) stake by 11% in Q2 2026, buying an estimated $302 and bringing the position to 586 shares worth $3.08K. The position accounts for ﹤0.01% of the portfolio, ranked #4340.

Allworth Financial first reported a position in LFCR in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.09K in Q4 2025. 98 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • Allworth Financial held 586 shares of Lifecore Biomedical worth $3.08K as of Q2 2026.
  • Allworth Financial bought 60 Lifecore Biomedical shares in Q2 2026, an estimated $302.
  • Lifecore Biomedical made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4340 holding.
  • Allworth Financial first reported a position in Lifecore Biomedical in Q2 2025 and has held it in 5 quarters since.
  • Allworth Financial's Lifecore Biomedical position peaked at $4.09K in Q4 2025.
  • 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.